NDC 60505-0117

NDC 60505-0117

NDC 60505-0117 is a in the category. It is labeled and distributed by .

Proprietary NameNDC 60505-0117
Marketing Category/

Packaging

NDC SPL Data Element Entries

NDC 60505-0117-5 [60505011705]

Terazosin CAPSULE
Marketing CategoryANDA
Application NumberANDA075498
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2001-04-12
Marketing End Date2017-10-31

NDC 60505-0117-0 [60505011700]

Terazosin CAPSULE
Marketing CategoryANDA
Application NumberANDA075498
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2001-04-12
Marketing End Date2017-10-31

NDC 60505-0117-7 [60505011707]

Terazosin CAPSULE
Marketing CategoryANDA
Application NumberANDA075498
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2001-04-12
Marketing End Date2017-10-31

NDC 60505-0117-1 [60505011701]

Terazosin CAPSULE
Marketing CategoryANDA
Application NumberANDA075498
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2001-04-12
Marketing End Date2017-10-31

Drug Details

Medicade Reported Pricing

60505011707 TERAZOSIN 5 MG CAPSULE

Pricing Unit: EA | Drug Type:

60505011705 TERAZOSIN 5 MG CAPSULE

Pricing Unit: EA | Drug Type:

60505011700 TERAZOSIN 5 MG CAPSULE

Pricing Unit: EA | Drug Type:
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.